Belite Bio, Inc. ADR (BLTE) has released an update.
Belite Bio, Inc has entered into a securities purchase agreement to issue and sell securities to an identified purchaser, subject to the terms of the agreement and relevant securities regulations. The transaction involves American Depositary Shares (ADSs) and warrants, with the closing of the sale contingent upon the satisfaction of certain conditions by a specified date. The agreement outlines detailed terms including definitions, purchase price, and various legal considerations.
For further insights into BLTE stock, check out TipRanks’ Stock Analysis page.
